SANGRIX INC
SGRXNASDAQ🏆 #5371 by market capUS Equity
$1.55▲ $0.11 (+6.90%)
LiveTrack SGRX
Get earnings, price moves & breaking news on Telegram
24h▲ 6.9%
7d▼ 6.6%
14d▼ 12.9%
30d▼ 50.3%
ytd▼ 96.8%
1y▼ 98.7%
🏦Market Cap
$6M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
100.0%
High
💵FCF Margin
—
⚖️P/S Ratio
34.9x
Expensive
Otter Score
56
Weak
Trading Snapshot
- Day Range
- $1.54 – $1.58
- 52-Week Range
- $1.40 – $166.70
- Volume
- $4.03B
- Avg Volume
- $5.12B
- Shares Outstanding
- 4.2M
- Next Earnings
- Oct 26, 2026
Fundamentals Snapshot
- Annual Revenue
- $51,961
- Last Q Revenue
- $12,213
- P/E Ratio
- —
- P/S Ratio
- 34.9x
- EPS (TTM)
- $-8.78
- Dividend Yield
- —
Why Investors Own SGRX
- ✓High-growth profile — revenue up +14.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 65% gross margin and 23% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SANGRIX INC
SGRXFinancial Trends
Revenue (TTM)The total money the company brought in from sales, before subtracting any costs.
$51,961▲ +15.5% YoY
Gross Margin (TTM)Of every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
64.7%▼ −0.4% YoY
Operating Income (TTM)Profit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$10,548▲ +15.5% YoY
Free Cash Flow (TTM)Cash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$11,795▲ +15.5% YoY
StockOtter · stockotter.spaceAbout SANGRIX INC
A company profile for SANGRIX INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
56/100
Analyst Price Target
ⓘAverage Target
$1.50
▼ −3.1% Downside
High Target$1.76
Low Target$1.15
Based on 19 analysts
Latest News & Updates
🚀
Barron’s·2h ago
SANGRIX INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift SGRX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
SANGRIX INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.